awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54115504-D2BCEF41-6C57-4740-8E6F-CBA6FF599E61
Q54115504-D2BCEF41-6C57-4740-8E6F-CBA6FF599E61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54115504-D2BCEF41-6C57-4740-8E6F-CBA6FF599E61
Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis.
P2860
Q54115504-D2BCEF41-6C57-4740-8E6F-CBA6FF599E61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54115504-D2BCEF41-6C57-4740-8E6F-CBA6FF599E61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d89b750436f13259be8c67d931a4fd038a14f56
P2860
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.